Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 13 | 2023 | 100 | 3.410 |
Why?
|
| Mass Screening | 14 | 2023 | 256 | 2.960 |
Why?
|
| Lung Neoplasms | 10 | 2023 | 423 | 2.660 |
Why?
|
| Colorectal Neoplasms | 8 | 2023 | 219 | 2.440 |
Why?
|
| Decision Making | 5 | 2022 | 189 | 2.300 |
Why?
|
| Primary Health Care | 9 | 2022 | 232 | 1.720 |
Why?
|
| Internship and Residency | 5 | 2017 | 319 | 1.270 |
Why?
|
| Electronic Health Records | 4 | 2020 | 179 | 1.220 |
Why?
|
| Students, Medical | 3 | 2022 | 126 | 1.080 |
Why?
|
| Access to Information | 2 | 2019 | 13 | 1.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2017 | 316 | 1.020 |
Why?
|
| Attitude of Health Personnel | 4 | 2016 | 183 | 0.960 |
Why?
|
| Computer-Assisted Instruction | 4 | 2015 | 24 | 0.910 |
Why?
|
| Humans | 52 | 2023 | 32274 | 0.860 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 130 | 0.850 |
Why?
|
| Internal Medicine | 4 | 2017 | 53 | 0.810 |
Why?
|
| Curriculum | 5 | 2022 | 203 | 0.740 |
Why?
|
| Patient Education as Topic | 6 | 2012 | 245 | 0.730 |
Why?
|
| Nursing Staff | 1 | 2022 | 7 | 0.720 |
Why?
|
| Caregivers | 2 | 2020 | 114 | 0.710 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 39 | 0.710 |
Why?
|
| Internet | 5 | 2019 | 202 | 0.660 |
Why?
|
| Privacy | 1 | 2020 | 9 | 0.640 |
Why?
|
| Steam | 1 | 2020 | 1 | 0.630 |
Why?
|
| Fires | 1 | 2020 | 9 | 0.620 |
Why?
|
| Philosophy | 2 | 2020 | 2 | 0.620 |
Why?
|
| United States | 14 | 2020 | 4072 | 0.610 |
Why?
|
| Hospitals | 1 | 2020 | 95 | 0.610 |
Why?
|
| User-Computer Interface | 2 | 2019 | 54 | 0.580 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 37 | 0.540 |
Why?
|
| Information Dissemination | 2 | 2016 | 52 | 0.540 |
Why?
|
| Science | 1 | 2017 | 8 | 0.530 |
Why?
|
| False Positive Reactions | 1 | 2017 | 27 | 0.530 |
Why?
|
| Health Literacy | 2 | 2015 | 28 | 0.520 |
Why?
|
| Patient Preference | 2 | 2015 | 48 | 0.520 |
Why?
|
| Health Education | 2 | 2015 | 149 | 0.500 |
Why?
|
| Medical Oncology | 1 | 2017 | 90 | 0.480 |
Why?
|
| Laboratories | 1 | 2016 | 18 | 0.470 |
Why?
|
| Male | 24 | 2020 | 19437 | 0.470 |
Why?
|
| Middle Aged | 19 | 2021 | 11848 | 0.460 |
Why?
|
| Historiography | 1 | 2015 | 1 | 0.460 |
Why?
|
| Mathematics | 1 | 2015 | 13 | 0.460 |
Why?
|
| Female | 24 | 2022 | 19942 | 0.450 |
Why?
|
| Alcohol-Related Disorders | 1 | 2015 | 21 | 0.450 |
Why?
|
| Physicians | 1 | 2017 | 163 | 0.450 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 91 | 0.420 |
Why?
|
| Prejudice | 2 | 2013 | 45 | 0.420 |
Why?
|
| Qualitative Research | 3 | 2022 | 179 | 0.400 |
Why?
|
| Prostatic Neoplasms | 3 | 2014 | 489 | 0.400 |
Why?
|
| Awareness | 1 | 2013 | 23 | 0.390 |
Why?
|
| Adult | 14 | 2023 | 9256 | 0.370 |
Why?
|
| Aged | 11 | 2021 | 10260 | 0.340 |
Why?
|
| Colonoscopy | 2 | 2023 | 45 | 0.320 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2020 | 23 | 0.310 |
Why?
|
| Smoking Cessation | 2 | 2023 | 211 | 0.310 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 1479 | 0.300 |
Why?
|
| Drug Industry | 1 | 2008 | 16 | 0.280 |
Why?
|
| Patient Compliance | 2 | 2007 | 205 | 0.280 |
Why?
|
| Telemedicine | 2 | 2020 | 122 | 0.280 |
Why?
|
| Medically Uninsured | 1 | 2008 | 35 | 0.280 |
Why?
|
| Multimedia | 2 | 2005 | 19 | 0.280 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 54 | 0.270 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 762 | 0.270 |
Why?
|
| Academic Medical Centers | 2 | 2022 | 161 | 0.270 |
Why?
|
| Patient Participation | 2 | 2022 | 90 | 0.270 |
Why?
|
| Schools, Medical | 2 | 2022 | 43 | 0.270 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 4 | 0.270 |
Why?
|
| Drug Therapy | 1 | 2007 | 15 | 0.260 |
Why?
|
| Retrospective Studies | 5 | 2020 | 3624 | 0.260 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2007 | 11 | 0.260 |
Why?
|
| North Carolina | 7 | 2016 | 1300 | 0.250 |
Why?
|
| Health Expenditures | 1 | 2007 | 66 | 0.250 |
Why?
|
| Tablets | 2 | 2022 | 10 | 0.250 |
Why?
|
| History, 20th Century | 2 | 2017 | 74 | 0.240 |
Why?
|
| Population Surveillance | 1 | 2007 | 120 | 0.240 |
Why?
|
| Feasibility Studies | 2 | 2019 | 308 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 907 | 0.230 |
Why?
|
| Pilot Projects | 5 | 2017 | 553 | 0.230 |
Why?
|
| Office Visits | 1 | 2005 | 72 | 0.210 |
Why?
|
| Government Programs | 1 | 2023 | 11 | 0.200 |
Why?
|
| Clinical Competence | 2 | 2016 | 330 | 0.200 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 22 | 0.190 |
Why?
|
| Occult Blood | 2 | 2017 | 12 | 0.190 |
Why?
|
| Ambulatory Care Facilities | 3 | 2019 | 84 | 0.190 |
Why?
|
| Interviews as Topic | 3 | 2016 | 194 | 0.180 |
Why?
|
| Program Evaluation | 5 | 2015 | 171 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1437 | 0.180 |
Why?
|
| Educational Measurement | 2 | 2017 | 113 | 0.180 |
Why?
|
| Depression | 2 | 2022 | 420 | 0.170 |
Why?
|
| Efficiency, Organizational | 2 | 2016 | 16 | 0.170 |
Why?
|
| Focus Groups | 1 | 2022 | 123 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2019 | 1425 | 0.170 |
Why?
|
| Obesity | 3 | 2013 | 1111 | 0.170 |
Why?
|
| Logistic Models | 3 | 2020 | 743 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2020 | 484 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2022 | 2316 | 0.170 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 245 | 0.160 |
Why?
|
| Research Design | 2 | 2017 | 314 | 0.160 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 82 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 167 | 0.160 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2020 | 3 | 0.160 |
Why?
|
| Fibroins | 1 | 2020 | 5 | 0.160 |
Why?
|
| Knowledge | 1 | 2020 | 13 | 0.160 |
Why?
|
| Endocrinology | 1 | 2019 | 2 | 0.160 |
Why?
|
| Monitoring, Ambulatory | 1 | 2019 | 8 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2021 | 121 | 0.160 |
Why?
|
| Thermodynamics | 1 | 2020 | 57 | 0.160 |
Why?
|
| Temperature | 1 | 2020 | 58 | 0.150 |
Why?
|
| Preventive Health Services | 1 | 2020 | 39 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2020 | 62 | 0.150 |
Why?
|
| Risk | 2 | 2017 | 305 | 0.150 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 117 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 212 | 0.140 |
Why?
|
| Disclosure | 1 | 2018 | 31 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 186 | 0.140 |
Why?
|
| Electroencephalography | 2 | 2016 | 75 | 0.140 |
Why?
|
| Drugs, Generic | 2 | 2008 | 14 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2019 | 112 | 0.140 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 388 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2017 | 68 | 0.130 |
Why?
|
| Patient Selection | 1 | 2019 | 272 | 0.130 |
Why?
|
| Time Factors | 3 | 2019 | 2204 | 0.130 |
Why?
|
| Sex Factors | 2 | 2016 | 655 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2016 | 13 | 0.130 |
Why?
|
| European Continental Ancestry Group | 3 | 2011 | 1076 | 0.120 |
Why?
|
| Locomotion | 1 | 2016 | 34 | 0.120 |
Why?
|
| Education, Medical | 1 | 2017 | 69 | 0.120 |
Why?
|
| Choline Kinase | 1 | 2016 | 2 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2016 | 21 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2016 | 38 | 0.120 |
Why?
|
| Logic | 1 | 2015 | 2 | 0.120 |
Why?
|
| England | 1 | 2015 | 4 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2021 | 820 | 0.110 |
Why?
|
| Family Practice | 1 | 2015 | 49 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 174 | 0.110 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 13 | 0.110 |
Why?
|
| Health Surveys | 1 | 2015 | 175 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 97 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 128 | 0.110 |
Why?
|
| African Americans | 3 | 2011 | 1335 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 255 | 0.100 |
Why?
|
| Prevalence | 1 | 2016 | 955 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1158 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2013 | 7 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 11 | 0.100 |
Why?
|
| Semantic Differential | 1 | 2013 | 5 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 33 | 0.100 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 42 | 0.100 |
Why?
|
| Bacteremia | 1 | 2013 | 66 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 287 | 0.100 |
Why?
|
| Data Collection | 2 | 2020 | 171 | 0.090 |
Why?
|
| Social Marketing | 1 | 2012 | 14 | 0.090 |
Why?
|
| Digital Rectal Examination | 2 | 2009 | 8 | 0.090 |
Why?
|
| MP3-Player | 1 | 2011 | 2 | 0.090 |
Why?
|
| Warfarin | 1 | 2011 | 32 | 0.090 |
Why?
|
| Urban Health Services | 1 | 2011 | 10 | 0.090 |
Why?
|
| Community Health Centers | 1 | 2011 | 12 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 324 | 0.080 |
Why?
|
| Program Development | 1 | 2011 | 93 | 0.080 |
Why?
|
| Research | 1 | 2011 | 81 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2012 | 128 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 3898 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 231 | 0.080 |
Why?
|
| Health Promotion | 1 | 2012 | 242 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 2008 | 7 | 0.070 |
Why?
|
| Masculinity | 1 | 2008 | 6 | 0.070 |
Why?
|
| Drug Costs | 1 | 2008 | 46 | 0.070 |
Why?
|
| Medicaid | 1 | 2008 | 101 | 0.070 |
Why?
|
| Formularies as Topic | 1 | 2007 | 2 | 0.070 |
Why?
|
| Prescription Fees | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cost Sharing | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cost Control | 1 | 2007 | 17 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2007 | 44 | 0.070 |
Why?
|
| Health Behavior | 1 | 2009 | 211 | 0.070 |
Why?
|
| Microcomputers | 1 | 2005 | 6 | 0.060 |
Why?
|
| Australia | 1 | 2005 | 35 | 0.060 |
Why?
|
| North America | 1 | 2005 | 31 | 0.060 |
Why?
|
| Attitude to Computers | 1 | 2005 | 16 | 0.060 |
Why?
|
| Europe | 1 | 2005 | 82 | 0.050 |
Why?
|
| Medical Records | 1 | 2005 | 75 | 0.050 |
Why?
|
| Health Services | 1 | 2005 | 40 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2005 | 78 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 191 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 651 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2005 | 148 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2005 | 138 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3934 | 0.050 |
Why?
|
| Infant | 2 | 2016 | 1010 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 541 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 47 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2240 | 0.040 |
Why?
|
| Silk | 1 | 2021 | 3 | 0.040 |
Why?
|
| Needles | 1 | 2021 | 29 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 263 | 0.040 |
Why?
|
| Food Supply | 1 | 2021 | 64 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 251 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 144 | 0.040 |
Why?
|
| Poliomyelitis | 1 | 2020 | 3 | 0.040 |
Why?
|
| Drug Storage | 1 | 2020 | 5 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 23 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 18 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2020 | 111 | 0.040 |
Why?
|
| Educational Status | 2 | 2012 | 167 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 65 | 0.040 |
Why?
|
| Social Environment | 1 | 2020 | 74 | 0.040 |
Why?
|
| Hospitalists | 1 | 1999 | 6 | 0.040 |
Why?
|
| Workload | 1 | 1999 | 32 | 0.040 |
Why?
|
| Animals | 2 | 2021 | 8199 | 0.040 |
Why?
|
| Patients | 1 | 2018 | 46 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 219 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 505 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 883 | 0.030 |
Why?
|
| Movement | 1 | 2016 | 61 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 45 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2016 | 5 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 13 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 9 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 87 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2015 | 39 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 143 | 0.030 |
Why?
|
| Mice | 1 | 2021 | 2571 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1895 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 244 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 204 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 131 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 47 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2015 | 91 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 190 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 717 | 0.030 |
Why?
|
| Apoptosis | 1 | 2016 | 375 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 362 | 0.030 |
Why?
|
| beta-Lactams | 1 | 2013 | 5 | 0.030 |
Why?
|
| Empirical Research | 1 | 2013 | 6 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 729 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 8 | 0.030 |
Why?
|
| Tetracycline | 1 | 2013 | 12 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2013 | 9 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 603 | 0.020 |
Why?
|
| Culture | 1 | 2013 | 34 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 292 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 666 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3416 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 7 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2011 | 21 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 179 | 0.020 |
Why?
|
| Mentors | 1 | 2011 | 33 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 595 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 75 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 757 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2011 | 122 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 242 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 59 | 0.020 |
Why?
|
| Attitude | 1 | 2008 | 37 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 139 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 65 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 1840 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 2648 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 3517 | 0.010 |
Why?
|
| Bed Occupancy | 1 | 1999 | 1 | 0.010 |
Why?
|
| Hospital Bed Capacity | 1 | 1999 | 5 | 0.010 |
Why?
|
| Benchmarking | 1 | 1999 | 24 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 144 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1999 | 187 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1999 | 137 | 0.010 |
Why?
|